The leading global platform for biopharma and medtech regulated digital health products

BrightInsight accelerates time to market for our customers’ digital health products, including apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD) across therapeutic areas.

Platform wheel graphic mobile
Learn More

Digital Health at BIO 2022

Learn More

CASE STUDY:
CSL Behring Launches Mobile App to Improve Treatment Experience for Patients with Rare Diseases

CSL Behring leveraged the BrightInsight Platform to launch a mobile app for adult patients with rare diseases who are taking Hizentra.

Read
Case study CSL phone screenshots stacked

BrightInsight and UCB Partner to Build Digital Care Solutions for Rare Diseases

Read Press Release
Ucb logo circle

BrightInsight Announces Partnership with Sanofi to Bring to Market a Next Generation Digital Companion App

The BrightInsight Platform was selected to accelerate development of one of Sanofi’s Best-In-Class Software as a Medical Device.

Learn More
Homepage sanofi

BrightInsight Named to the 2021 CB Insights Digital Health 150 List of Most Innovative Digital Health Startups

Learn More
Homepage split award digital health 150 2021

WHITE PAPER:
Expectation vs. Reality: Cost and Time to Bring SaMD to Market

Insights from top digital health executives on how to speed time to market and lower costs for SaMD solutions.

Read the White Paper
White paper expectation vs reality cost and time to bring samd to market pretty cover

BrightInsight Announces $101M in Series C Funding!

Led by General Catalyst, the Financing will Fuel BrightInsight’s Hypergrowth as the Leading Global Regulated Digital Health Platform for Biopharma and Medtech

Learn More
Series c funding 101 M

Blog

How Biopharma Commercial and R&D Can Partner to Accelerate Digital Innovation

Read More

How Roche and BrightInsight Launched a Dose Management Software as a Medical Device in 6 months

Watch an on-demand webinar with Paul Upham, Head of Smart Devices at Roche/Genentech, where he discusses how Roche launched a regulated SaMD dosing calculator for treating hemophilia A in Europe.

Watch
Dosing calculator with roche

Treatment Selection in Autoimmune: How Digital Can Unlock Opportunities for Biopharma

Research insights into the biggest digital health opportunities for biopharma in biologics for autoimmune conditions

Read Now
White paper treatment selection in autoimmune pretty cover

Careers

Join our award-winning team

View Jobs
BrightInsight brand arrows

Read our latest Industry Brief with Biopharma Dive to hear from industry experts on how to approach the regulatory strategy for your underlying digital health infrastructure.

Using a regulated infrastructure alleviates regulatory concerns as you’re developing your product over years and years. You can be confident that from an infrastructure standpoint, you’ll be compliant.

- Bradley Merrill Thompson, Epstein Becker & Green, P.C.